We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors (IFF) Q1 Earnings Beat, Sales Dip Y/Y
Read MoreHide Full Article
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of $1.13 per share in first-quarter 2024, beating the Zacks Consensus Estimate of 84 cents. The bottom line improved 30% from the year-ago quarter.
Including one-time items, the company reported earnings of 23 cents against the prior-year quarter’s loss of 4 cents.
International Flavors’ net sales were $2.9 billion in the March-end quarter, decreasing 4.2% year over year. The top line surpassed the Zacks Consensus Estimate of $2.81 billion. In the January-March quarter, currency-neutral sales grew 5% year over year.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
In the reported quarter, International Flavors’ cost of goods sold was down 9.1% year over year to $1.88billion. The gross profit rose 6.2% year over year to $1.02 billion. The gross margin came in at 35.3% compared with 31.8% in the year-ago quarter.
Research and development expenses increased 3.1% year over year to $166 million. The selling and administrative expenses rose 7.9% year over year to $490 million in the first quarter. The adjusted operating EBITDA came in at $578 million, up 14.9% from the prior-year quarter’s $503 million. The adjusted operating EBITDA margin was 19.9% compared with the year-ago quarter’s 16.6%.
Segmental Performances
Revenues in the Nourish segment fell 9.5% year over year to $1.5 billion in the March-end quarter. The figure beat our estimate of $1.46 billion. The adjusted operating EBITDA was $216 million, up 3.8% year over year. Our estimate for the segment’s adjusted EBITDA was $181 million.
Revenues generated in the Health & Bioscience segment were $531 million compared with the year-earlier quarter’s $513 million. Our estimate was $511 million for the same. The adjusted operating EBITDA was $159 million in the quarter compared with $131 million in the prior-year quarter. Our estimate for the segment’s adjusted EBITDA was $142 million.
The Scent segment’s revenues were $645 million compared with the year-ago quarter’s $608 million. The figure was in line with our estimate. The adjusted operating EBITDA improved 49.5% year over year to $157 million. Our model had projected an EBITDA of $101 million for the segment.
Revenues in Pharma Solutions were $227 million in the first quarter, down 10.3% year over year. The figure surpassed our estimate of $223 million. The adjusted operating EBITDA fell 22% year over year to $46 million. Our model had projected an EBITDA of $52 million for the segment.
Financial Position
International Flavors had cash, cash equivalents, and restricted cash of $739 million at the end of the first quarter, up from the $709 million witnessed at the end of 2023. The long-term debt was $9.2 billion at the first-quarter end, flat with that reported on Dec 31, 2023.
International Flavors generated $99 million of cash in operating activities in the first quarter compared with $127 million in the prior-year quarter.
2024 Guidance
International Flavors expects sales for 2024 to be at the higher end of $10.8-$11.1 billion. Volume is anticipated to be near the higher end of its earlier stated expectation of flat to up 3%. The company expects pricing to increase 1% year over year, up from the previously stated decline of 2.5%. Adjusted EBITDA is expected between $1.9 billion and $2.1 billion.
Price Performance
In the past year, IFF’s shares have lost 5.3% compared with the industry’s decline of 23.8%.
Kimberly-Clark Corporation (KMB - Free Report) posted first-quarter 2024 adjusted earnings of $2.01 per share, surpassing the Zacks Consensus Estimate of $1.61. The bottom line increased 20% year over year, courtesy of higher adjusted operating profit.
Kimberly-Clark’s sales totaled $5.1 billion, surpassing the consensus estimate of $5.08 billion. The metric inched down 1% compared with the year-ago period.
Tilray Brands, Inc. (TLRY - Free Report) reported break-even quarterly earnings per share, whereas the Zacks Consensus Estimate was pegged at a loss of 4 cents. Notably, the company reported a loss of 4 cents a year ago. It posted revenues of $188.3 million for the quarter ended February 2024, missing the consensus estimate of $200 million. The top line increased 29% year over year.
Newell Brands Inc. (NWL - Free Report) posted break-even earnings in first-quarter 2024 against earnings per share of 6 cents in the year-ago quarter. Meanwhile, the consensus mark was pegged at a loss of 7 cents per share.
Net sales declined 8.4% year over year to $1.7 billion on lower core sales, and the impacts of business exits and adverse foreign exchange. Nonetheless, the metric exceeded the consensus estimate of $1.6 billion.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
International Flavors (IFF) Q1 Earnings Beat, Sales Dip Y/Y
International Flavors & Fragrances Inc. (IFF - Free Report) reported adjusted earnings of $1.13 per share in first-quarter 2024, beating the Zacks Consensus Estimate of 84 cents. The bottom line improved 30% from the year-ago quarter.
Including one-time items, the company reported earnings of 23 cents against the prior-year quarter’s loss of 4 cents.
International Flavors’ net sales were $2.9 billion in the March-end quarter, decreasing 4.2% year over year. The top line surpassed the Zacks Consensus Estimate of $2.81 billion. In the January-March quarter, currency-neutral sales grew 5% year over year.
International Flavors & Fragrances Inc. Price, Consensus and EPS Surprise
International Flavors & Fragrances Inc. price-consensus-eps-surprise-chart | International Flavors & Fragrances Inc. Quote
Operational Highlights
In the reported quarter, International Flavors’ cost of goods sold was down 9.1% year over year to $1.88billion. The gross profit rose 6.2% year over year to $1.02 billion. The gross margin came in at 35.3% compared with 31.8% in the year-ago quarter.
Research and development expenses increased 3.1% year over year to $166 million. The selling and administrative expenses rose 7.9% year over year to $490 million in the first quarter. The adjusted operating EBITDA came in at $578 million, up 14.9% from the prior-year quarter’s $503 million. The adjusted operating EBITDA margin was 19.9% compared with the year-ago quarter’s 16.6%.
Segmental Performances
Revenues in the Nourish segment fell 9.5% year over year to $1.5 billion in the March-end quarter. The figure beat our estimate of $1.46 billion. The adjusted operating EBITDA was $216 million, up 3.8% year over year. Our estimate for the segment’s adjusted EBITDA was $181 million.
Revenues generated in the Health & Bioscience segment were $531 million compared with the year-earlier quarter’s $513 million. Our estimate was $511 million for the same. The adjusted operating EBITDA was $159 million in the quarter compared with $131 million in the prior-year quarter. Our estimate for the segment’s adjusted EBITDA was $142 million.
The Scent segment’s revenues were $645 million compared with the year-ago quarter’s $608 million. The figure was in line with our estimate. The adjusted operating EBITDA improved 49.5% year over year to $157 million. Our model had projected an EBITDA of $101 million for the segment.
Revenues in Pharma Solutions were $227 million in the first quarter, down 10.3% year over year. The figure surpassed our estimate of $223 million. The adjusted operating EBITDA fell 22% year over year to $46 million. Our model had projected an EBITDA of $52 million for the segment.
Financial Position
International Flavors had cash, cash equivalents, and restricted cash of $739 million at the end of the first quarter, up from the $709 million witnessed at the end of 2023. The long-term debt was $9.2 billion at the first-quarter end, flat with that reported on Dec 31, 2023.
International Flavors generated $99 million of cash in operating activities in the first quarter compared with $127 million in the prior-year quarter.
2024 Guidance
International Flavors expects sales for 2024 to be at the higher end of $10.8-$11.1 billion. Volume is anticipated to be near the higher end of its earlier stated expectation of flat to up 3%. The company expects pricing to increase 1% year over year, up from the previously stated decline of 2.5%. Adjusted EBITDA is expected between $1.9 billion and $2.1 billion.
Price Performance
In the past year, IFF’s shares have lost 5.3% compared with the industry’s decline of 23.8%.
Image Source: Zacks Investment Research
Zacks Rank
International Flavors currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Performances of Peers
Kimberly-Clark Corporation (KMB - Free Report) posted first-quarter 2024 adjusted earnings of $2.01 per share, surpassing the Zacks Consensus Estimate of $1.61. The bottom line increased 20% year over year, courtesy of higher adjusted operating profit.
Kimberly-Clark’s sales totaled $5.1 billion, surpassing the consensus estimate of $5.08 billion. The metric inched down 1% compared with the year-ago period.
Tilray Brands, Inc. (TLRY - Free Report) reported break-even quarterly earnings per share, whereas the Zacks Consensus Estimate was pegged at a loss of 4 cents. Notably, the company reported a loss of 4 cents a year ago. It posted revenues of $188.3 million for the quarter ended February 2024, missing the consensus estimate of $200 million. The top line increased 29% year over year.
Newell Brands Inc. (NWL - Free Report) posted break-even earnings in first-quarter 2024 against earnings per share of 6 cents in the year-ago quarter. Meanwhile, the consensus mark was pegged at a loss of 7 cents per share.
Net sales declined 8.4% year over year to $1.7 billion on lower core sales, and the impacts of business exits and adverse foreign exchange. Nonetheless, the metric exceeded the consensus estimate of $1.6 billion.